John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 5,016 shares at $43.81 ($220K) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Open-market sale of $220k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.80 | 2,419 | $106K | 48.2% |
| 2 | $43.81 | 2,439 | $107K | 48.6% |
| 3 | $44.41 | 59 | $3K | 1.2% |
| 4 | $44.50 | 99 | $4K | 2.0% |
| Total | $43.82 avg | 5,016 | $220K | 100% |
| Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |
| EWTX | SELL | 2024-02-09 | $834K | — | Filing → |